Al-Razi Medical Co.

9572.SRSAUHealthcare● Active

$29.22

+$0.90(+3.18%)

Market Cap$44414400

P/E Ratio—

52W High$45.7

52W Low$25.1

Avg Volume6K

Open$29.50

Beta0.35

Overview

Al-Razi Medical Co. (9572.SR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

9572.SR · free cash flow · updated Jun 15, 2026

Core FCF metrics

9572.SR · FCF · TTM · margin & CAGR

Free cash flow was $3.8M for FY2025 (fiscal year ending 2025-12-31), up 252.6% year-over-year The FCF margin was 5.2%.

FY2025 Free Cash Flow$3.8M▲ +252.6% YoY

Trailing 12M (TTM)$4.9Mtrailing 4 quarters sum

FCF Margin5.2%$3.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

9572.SR · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$5.8M(2M)$3.8M▲ +252.6%5.2%

FY2024$5.0M(4M)$1.1M▲ +9.3%1.8%

FY2023$5.8M(5M)$996,816▲ +211.7%1.6%

FY2022$2.0M(3M)−$892,006▲ +68.9%-1.7%

FY2021−$1.7M(1M)−$2.9M—-6.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

9572.SR · P/FCF · FCF yield · FCF per share

Al-Razi Medical Co. (9572.SR) trades at a FCF yield of 8.65% and a price-to-free-cash-flow ratio of 9.0x. FCF per share stands at $3.26, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

8.65%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$3.26

TTM FCF ÷ Shares Outstanding

Price / FCF

x9.0

Share Price ÷ FCF per Share

EV / FCF (TTM)

x14.6

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

9572.SR · cash flow statement · operating / investing / financing

For FY2025, Al-Razi Medical Co. generated $5.8M in operating cash flow and spent 2M in capital expenditures, yielding $3.8M in free cash flow.

Operating Activities

+$5.8M

Cash from core business operations

2025-12-31

Investing Activities

−$2.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$4.3M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($5.8M) − |CapEx| (2M) = FCF ($3.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

9572.SR vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Al-Razi Medical Co.YOU

9572.SR

$3.8M+252.6%5.2%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Al-Razi Medical Co. (9572.SR) reported free cash flow of $3.8M for FY2025 (fiscal year ending 2025-12-31), up 252.6% year-over-year. The FCF margin was 5.2%.

Based on available data, Al-Razi Medical Co. has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $3.8M in FY2025.

Al-Razi Medical Co.'s FCF yield is 8.65% and price-to-FCF ratio is 9.0x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

9572.SR free cash flow · 8 questions

Al-Razi Medical Co. free cash flow was $3.8M for FY2025, up 252.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $4.9M.

9572.SR free cash flow9572.SR FCF9572.SR FCF 20259572.SR free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Al-Razi Medical Co. · Al-Razi Medical Co. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026